Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
17 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/17/2947255/0/en/ANEW-MEDICAL-Inc-Announces-Name-Change-to-Klotho-Neurosciences-Inc.html
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940419/0/en/Healthy-Longevity-is-One-of-Key-Development-Goals-of-ANEW-s-Novel-Gene-Therapy.html
21 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/21/2933313/0/en/ANEW-MEDICAL-INC-Acquires-License-to-Needle-Free-Dry-Powder-Autoinjector-from-Transfertech-Sherbrooke-TTS.html
19 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/19/2931951/0/en/ANEW-MEDICAL-INC-Appoints-New-CFO.html
15 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/15/2930708/0/en/ANEW-MEDICAL-INC-Strengthens-Intellectual-Property-Protection-with-U-S-Patent-Issuance-for-Its-Secreted-RNA-Splice-Variant-of-the-Human-Klotho-Gene-Used-for-the-Treatment-of-Neurod.html
09 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/09/2927628/0/en/ANEW-MEDICAL-INC-Pursues-Neurological-Approach-to-Treating-Weight-Loss-and-Eating-Disorders-through-Melanocortin-Receptor-Binding-Peptides.html
Details:
The collaboration aims to focus on the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Lead Product(s): Klotho Gene Therapy
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Cell and Gene therapy
Sponsor: Japan’s Okinawa Research Center
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 27, 2024
Lead Product(s) : Klotho Gene Therapy
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Japan’s Okinawa Research Center
Deal Size : Undisclosed
Deal Type : Partnership
ANEW MEDICAL Partners with Okinawa Research Center to Study Klotho Gene
Details : The collaboration aims to focus on the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 27, 2024
Details:
ANEW intends to use the proceeds from the transaction to progress its lead gene therapy programs including, Alpha Klotho-based gene therapy being developed for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).
Lead Product(s): Alpha Klotho-based Gene Therapy
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Cell and Gene therapy
Sponsor: Redwoods Acquisition Corp.
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger May 30, 2023
Lead Product(s) : Alpha Klotho-based Gene Therapy
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Redwoods Acquisition Corp.
Deal Size : Undisclosed
Deal Type : Merger
Anew Medical, Inc. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
Details : ANEW intends to use the proceeds from the transaction to progress its lead gene therapy programs including, Alpha Klotho-based gene therapy being developed for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
May 30, 2023
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?